ロード中...
Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong – A decision analysis
Trivalent influenza vaccine (TIV) selects one of the 2 co-circulating influenza B lineages whereas quadrivalent influenza vaccine (QIV) includes both lineages. We examined potential cost-effectiveness of QIV versus TIV from perspectives of healthcare provider and society of Hong Kong. A decision tre...
保存先:
| 出版年: | Hum Vaccin Immunother |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514204/ https://ncbi.nlm.nih.gov/pubmed/25714506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1011016 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|